← Open Payments lookup

DOUGLAS DOLNAK: Open Payments

NPI 1316147085 · NATIONAL CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,181 in 69 payments from 12 companies in 2025. Trend: 2023 $1,684 · 2024 $1,333 · 2025 $2,181

Food & beverage: $2,173Education: $8
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.15$408
Alkermes, Inc.7$341
Teva Pharmaceuticals USA, Inc.8$332
Otsuka America Pharmaceutical, Inc.9$281
E.R. Squibb & Sons, L.L.C.8$268
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$175
ABBVIE INC.7$141
Lundbeck LLC3$74
Axsome Therapeutics, Inc.2$52
Janssen Pharmaceuticals, Inc2$52

Products named: INGREZZA, REXULTI, COBENFY, UZEDY, ARISTADA, CAPLYTA, VRAYLAR, LYBALVI.

Industry payments across CA — which companies pay providers there.